Free Trial

Theracryf (TCF) Competitors

GBX 0.25 0.00 (0.00%)
As of 09/12/2025 10:25 AM Eastern

TCF vs. HARL, SOS, VEL, ING, SPO, NWT, IX, TREE, STL, and HWC

Should you be buying Theracryf stock or one of its competitors? The main competitors of Theracryf include Harland & Wolff Group (HARL), Sosandar (SOS), Velocity Composites (VEL), Ingenta (ING), Sportech (SPO), Newmark Security (NWT), i(x) Net Zero (IX), Cambium Global Timberland (TREE), Stilo International (STL), and Highway Capital (HWC). These companies are all part of the "banking" industry.

Theracryf vs. Its Competitors

Harland & Wolff Group (LON:HARL) and Theracryf (LON:TCF) are both small-cap banking companies, but which is the better investment? We will contrast the two companies based on the strength of their earnings, institutional ownership, valuation, profitability, risk, analyst recommendations, dividends and media sentiment.

In the previous week, Harland & Wolff Group's average media sentiment score of 0.00 equaled Theracryf'saverage media sentiment score.

Company Overall Sentiment
Harland & Wolff Group Neutral
Theracryf Neutral

Harland & Wolff Group has a beta of 3.14, meaning that its stock price is 214% more volatile than the S&P 500. Comparatively, Theracryf has a beta of 1.42, meaning that its stock price is 42% more volatile than the S&P 500.

60.8% of Harland & Wolff Group shares are held by institutional investors. Comparatively, 7.8% of Theracryf shares are held by institutional investors. 16.3% of Harland & Wolff Group shares are held by insiders. Comparatively, 22.7% of Theracryf shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Theracryf has lower revenue, but higher earnings than Harland & Wolff Group. Theracryf is trading at a lower price-to-earnings ratio than Harland & Wolff Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Harland & Wolff Group£86.91M0.00-£43.09M-£0.24N/A
TheracryfN/AN/A-£5.45M-£0.00-69.44

Harland & Wolff Group has a net margin of -49.57% compared to Theracryf's net margin of -792.17%. Harland & Wolff Group's return on equity of 0.00% beat Theracryf's return on equity.

Company Net Margins Return on Equity Return on Assets
Harland & Wolff Group-49.57% N/A -16.78%
Theracryf -792.17%-99.97%-48.26%

Summary

Harland & Wolff Group beats Theracryf on 7 of the 10 factors compared between the two stocks.

Get Theracryf News Delivered to You Automatically

Sign up to receive the latest news and ratings for TCF and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

TCF vs. The Competition

MetricTheracryfBiotechnology IndustryMedical SectorLON Exchange
Market Cap£5.37M£153.68M£5.84B£2.51B
Dividend YieldN/A3.78%5.68%5.30%
P/E Ratio-69.4441.0875.415,410.94
Price / SalesN/A4,942.15515.8196,613.70
Price / CashN/A13.1937.5627.93
Price / Book0.29103.7512.157.77
Net Income-£5.45M-£90.99M£3.29B£5.89B
7 Day Performance1.21%2.86%0.73%6.51%
1 Month Performance9.17%21.20%4.99%55.22%
1 Year Performance-64.03%526.77%62.53%154.12%

Theracryf Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
TCF
Theracryf
N/AGBX 0.25
flat
N/A-64.0%£5.37MN/A-69.4410Gap Up
High Trading Volume
HARL
Harland & Wolff Group
N/AN/AN/AN/A£14.49M£86.91M-34.9081News Coverage
SOS
Sosandar
N/AGBX 5.02
-8.7%
N/A-49.3%£12.47M£37.13M-2,282.73170Gap Down
VEL
Velocity Composites
1.1163 of 5 stars
GBX 20.74
+2.1%
GBX 60
+189.3%
-53.0%£11.34M£22.70M-1,513.87102Gap Down
ING
Ingenta
N/AGBX 61.48
+0.8%
N/A-47.8%£8.92M£10.20M714.8865,000
SPO
Sportech
N/AN/AN/AN/A£8.40M£26.98M-1,680.00217,000Gap Up
High Trading Volume
NWT
Newmark Security
N/AGBX 77.40
-14.0%
N/A-2.3%£7.26M£22.13M-2,856.09102Positive News
Gap Down
IX
i(x) Net Zero
N/AN/AN/AN/A£6.99M£80.05M14.8132,200Gap Up
High Trading Volume
TREE
Cambium Global Timberland
N/AN/AN/AN/A£4.98M£4.57B11.271,250Gap Down
High Trading Volume
STL
Stilo International
N/AN/AN/AN/A£3.42M£1.42M30.001,907Gap Up
HWC
Highway Capital
N/AN/AN/AN/A£1.78MN/A0.003,630Gap Up

Related Companies and Tools


This page (LON:TCF) was last updated on 9/14/2025 by MarketBeat.com Staff
From Our Partners